SID 2026Late-breaking abstract LB1079Laboratory research
Abrocitinib reduces tissue-resident memory T cells and restores epidermal barrier in atopic dermatitis
Results from JADE MOA trial
Piccini I, Koudounas S, Ludwig RJ, Encinas G, Watkins M, Edelkamp J, Bertolini M
SID Annual Meeting 2026Late-breaking abstractsChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Atopic dermatitis & eczemaSkin biologyJAK inhibitors & other targeted pills
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1110 · Not in PubMed: details from Crossref